Drug Shortage Report for SUPRAX

Last updated on 2023-01-26 History
Report ID 177149
Drug Identification Number 00868965
Brand name SUPRAX
Common or Proper name Cefixime for oral suspension
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CEFIXIME
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 50 mL
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-01
Estimated end date 2023-02-03
Actual end date 2023-01-25
Shortage status Resolved
Updated date 2023-01-26
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-12-05 English Compare
v2 2022-12-05 French Compare
v3 2023-01-24 English Compare
v4 2023-01-24 French Compare
v5 2023-01-25 English Compare
v6 2023-01-25 French Compare
v7 2023-01-26 English Compare

Showing 1 to 7 of 7